Search
Search Results
##search.searchResults.foundPlural##
-
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1590PDF: 932HTML: 2008Figure: 188Tables: 199ALL revision 1: 287response to reviewer: 193 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2703PDF: 981HTML: 3725 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
878PDF: 493HTML: 1310 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6439PDF: 2178HTML: 14139Untitled: 213figure: 199 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2411PDF: 1208HTML: 281 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1410HTML: 384PDF: 982Suppl. Files: 482 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1446PDF: 578HTML: 229 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2171PDF: 794HTML: 1074Spirometry in SCA patients before transplant: 220Spirometry in SCA patients post transplant: 193 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2245PDF: 1778HTML: 824 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2821PDF: 997HTML: 4721 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4393PDF: 1406HTML: 2181 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3265PDF: 1886HTML: 3683 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1131PDF: 575Suppl. Files: 136HTML: 410 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1485PDF: 1045HTML: 128 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1350PDF: 481HTML: 18620Figure 1: 179Figure 2: 160Figure 3: 177Figure 4: 215Figure 5: 188 -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
1481PDF: 747HTML: 4592Figure 1: Chest radiograph: 226Figure 2: Flow cytometer analysis of pleural fluid: 198 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2515PDF: 900HTML: 2554 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
758PDF: 477HTML: 6277 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1272PDF: 877HTML: 262 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1304PDF: 539HTML: 23124 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2077PDF: 825HTML: 1216 -
-
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
842PDF: 552HTML: 4026 -
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4493PDF: 3686HTML: 367 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1441PDF: 711HTML: 1384cover letter: 220 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1342PDF: 612HTML: 3843







